心臟衰竭POC 和 LOC 設備市場：按設備類型、測試類型、技術、應用分類 - 2025-2030 年全球預測

2023年，心臟衰竭POC和LOC設備市場價值為9613萬美元，預計到2024年將達到1.0887億美元，複合年成長率為14.45%，到2030年將達到2.4737億美元。

心臟衰竭照護端 (POC) 和晶片實驗室 (LOC) 設備包括專為早期檢測而設計的手持式和行動裝置，可在患者所在地進行快速、準確的診斷，這徹底改變了心臟護理。這些技術的範圍涵蓋醫院、診所和居家醫療，重點是易用性和及時診斷，這對於有效的心臟衰竭管理至關重要。由於人口老化、生活方式的改變及其帶來的巨大醫療負擔，心臟病的盛行率不斷增加，因此對 POC 和 LOC 設備的需求產生了。 POC 和 LOC 設備的應用擴展到各種環境，有助於即時介入和持續病患監測。最終用途範圍包括醫院、診斷實驗室和個人化醫療，服務於都市區和農村地區。該市場的關鍵成長要素包括技術進步、醫療保健意識的提高以及對可攜式診斷解決方案不斷成長的需求。人工智慧和物聯網的集合成為先進的診斷能力鋪平了道路，並代表了巨大的成長機會。公司可以透過投資人工智慧驅動的分析和生物感測技術來抓住這些機會，以提高其設備的效率和可用性。然而，高昂的開發成本、監管條件和有限的報銷環境等障礙構成了重大障礙。他們還必須解決當前技術限制和資料安全問題等限制。為了推動成長，微型感測器、增強資料整合和即時分析等技術創新是有前景的領域。對低成本製造技術的進一步研究可以擴大可及性，降低價格敏感度並開拓新市場。心臟衰竭POC和市場動態市場是一個動態市場，其特徵是技術快速發展和激烈競爭。全面了解監管途徑、促進合作以及注重以患者為中心的設計對於利用新機會和克服挑戰至關重要。

市場動態：針對快速發展的心臟衰竭POC 和 LOC 設備市場揭示的關鍵市場見解

供需的動態交互作用正在改變心臟衰竭POC 和 LOC 設備市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

• 市場促進因素
  • 對疾病早期診斷的需求日益增加，以降低醫療費用
  • 加大力度開發帶有感測器和其他配件的一次性低成本 LOC 設備
  • 政府更多地採用 POC 和 LOC 設備，以緩解不斷成長的醫療保健支出
• 市場限制因素
  • 對於具有執行多項測試的試劑盒的 POC 設備缺乏標準報銷
• 市場機會
  • 技術進步增加了新型生物標記鑑定的研究活動
  • 用於分析 LOC 測定資料以進行治療監測的預測建模技術的新進展
• 市場挑戰
  • 居民的可及性和意識下降

波特五力：駕馭心臟衰竭POC 和 LOC 設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心臟衰竭POC 和 LOC 設備市場的外部影響

外部宏觀環境因素在塑造心臟衰竭POC 和 LOC 設備市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解心臟衰竭POC 和 LOC 設備市場的競爭格局

對心臟衰竭POC 和 LOC 設備市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心臟衰竭POC 和 LOC 設備市場供應商的績效評估

FPNV定位矩陣是評估心臟衰竭POC和LOC設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製心臟衰竭POC 和 LOC 設備市場的成功之路

心臟衰竭POC 和 LOC 設備市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 為了降低醫療成本，對疾病早期診斷的需求不斷增加。
    • 開發具有感測器和其他配件的一次性低成本 LOC 設備
    • 政府擴大採用 POC 和 LOC 設備，以緩解不斷上漲的醫療成本
  • 抑制因素
    • 對於具有執行多項測試的試劑盒的 POC 設備沒有標準報銷
  • 機會
    • 促進識別新生物標記的研究工作的技術進步
    • 用於分析 LOC 測定資料以進行治療監測的預測建模技術的新進展
  • 任務
    • 居民的可及性和意識下降
• 市場區隔分析
  • 設備類型：由於易於使用，照護現場設備的使用正在各種環境中擴展。
  • 應用：為醫院提供全面、先進的醫療保健解決方案
• 波特五力分析
• PESTEL分析
  • 政治的
  • 經濟
  • 社群
  • 技術的
  • 合法地
  • 環境

第 6 章心臟衰竭POC 和 LOC 設備市場（按設備類型）

• 實驗室晶片(LOC) 設備
• 照護現場(POC) 設備

第 7 章按測試類型分類的心臟衰竭POC 和 LOC 設備市場

• 基因組測試
• 代謝體學測試
• 蛋白質體測試

第 8 章心臟衰竭POC 和 LOC 設備市場：依技術分類

• 電化學感測
• 微流體
• 光學感

第 9 章心臟衰竭POC 和 LOC 設備市場：按應用分類

• 輔助生活醫療設施
• 診所
• 房子
• 醫院
• 實驗室

第10章美洲心臟衰竭POC和LOC設備市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太地區心臟衰竭POC和LOC設備市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲心臟衰竭POC和LOC設備市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
  • 羅氏診斷印度公司推出 NT-proBNP 檢測，用於糖尿病患者心臟衰竭的早期檢測
  • FDA核准Eko Health 的人工智慧聽診器能夠快速偵測低射血分數，增強心臟衰竭的早期診斷
  • 羅氏以 3.5 億美元收購 LumiraDx照護現場技術，旨在擴大去分散式檢查產品組合
• 戰略分析和建議

公司名單

• Abbott Laboratories
• ACON Laboratories Inc.
• AstraZeneca PLC
• Becton, Dickinson and Company
• bioMerieux SA
• BioTelemetry, Inc. by Royal Philips
• Boditech Med Inc.
• Danaher Corporation
• Eko Health, Inc.
• F. Hoffmann-La Roche Ltd.
• Jant Pharmacal Corporation
• Johari Digital India Limited
• Lepu Medical Technology（Beijing）Co.,Ltd.
• Lupin Limited
• Masimo Corporation
• Medtronic PLC
• Novartis AG
• Quidel Corporation
• Sanner GmbH
• Siemens Healthineers AG
• Trinity Biotech PLC
• uFluidix Inc.

The Heart Failure POC & LOC Devices Market was valued at USD 96.13 million in 2023, expected to reach USD 108.87 million in 2024, and is projected to grow at a CAGR of 14.45%, to USD 247.37 million by 2030.

Heart Failure Point-of-Care (POC) and Lab-on-Chip (LOC) devices have revolutionized cardiac care by enabling rapid and accurate diagnosis at the patient's location, encompassing handheld and portable devices designed for early detection. The scope of these technologies spans hospitals, clinics, and home care settings, emphasizing ease of use and timely diagnosis, which are crucial for effective heart failure management. The necessity for POC and LOC devices arises from the increasing prevalence of heart ailments driven by aging populations, lifestyle changes, and the significant healthcare burden they present. Their applications extend across various settings, facilitating immediate intervention and ongoing patient monitoring. The end-use scope includes hospitals, diagnostic laboratories, and personalized care, serving urban and rural communities alike. Key growth factors for this market include technological advancements, rising healthcare awareness, and increasing demand for portable diagnostic solutions. The integration of AI and IoT is paving the way for advanced diagnostic capabilities, marking significant growth opportunities. Companies could seize these opportunities by investing in AI-powered analytics and bio-sensing technologies to enhance device efficiency and user-friendliness. However, barriers such as high development costs, regulatory challenges, and limited reimbursement landscapes pose significant obstacles. Limitations like current technological constraints and data security concerns also need addressing. To foster growth, innovation in miniaturized sensors, enhanced data integration, and real-time analytics are promising areas. Further research in low-cost manufacturing techniques could broaden accessibility and reduce price sensitivity, unlocking new markets. The market for heart failure POC and LOC devices is dynamic, characterized by rapid technological evolution and competitive intensity. A thorough understanding of regulatory pathways, fostering collaborations, and a focus on patient-centered design will be pivotal in capitalizing on emerging opportunities and steering through challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Failure POC & LOC Devices Market

The Heart Failure POC & LOC Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for early diagnosis of diseases to reduce healthcare costs
  • Growing development of disposable and low-cost LOC devices with sensors and other accessories
  • Rising adoption of POC and LOC devices by governments to alleviate the rising healthcare expenditure
• Market Restraints
  • Lack of standard reimbursement for POC devices with a cartridge that performs multiple tests
• Market Opportunities
  • Advancements in technology to increase research activities for the identification of novel biomarkers
  • Emerging development of predictive-modeling techniques to analyze the LOC assays data for therapy monitoring
• Market Challenges
  • Reduced accessibility and awareness among the population

Porter's Five Forces: A Strategic Tool for Navigating the Heart Failure POC & LOC Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Failure POC & LOC Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Failure POC & LOC Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Failure POC & LOC Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Failure POC & LOC Devices Market

A detailed market share analysis in the Heart Failure POC & LOC Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Failure POC & LOC Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Failure POC & LOC Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Failure POC & LOC Devices Market

A strategic analysis of the Heart Failure POC & LOC Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Failure POC & LOC Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories Inc., AstraZeneca PLC, Becton, Dickinson and Company, bioMerieux SA, BioTelemetry, Inc. by Royal Philips, Boditech Med Inc., Danaher Corporation, Eko Health, Inc., F. Hoffmann-La Roche Ltd., Jant Pharmacal Corporation, Johari Digital India Limited, Lepu Medical Technology(Beijing)Co.,Ltd., Lupin Limited, Masimo Corporation, Medtronic PLC, Novartis AG, Quidel Corporation, Sanner GmbH, Siemens Healthineers AG, Trinity Biotech PLC, and uFluidix Inc..

Market Segmentation & Coverage

This research report categorizes the Heart Failure POC & LOC Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Device Type, market is studied across Lab-on-a-Chip (LOC) Devices and Point-of-Care (POC) Devices.
• Based on Test Type, market is studied across Genomic Testing, Metabolomic Testing, and Proteomic Testing.
• Based on Technology, market is studied across Electrochemical Sensing, Microfluidics, and Optical Sensing.
• Based on Application, market is studied across Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, and Laboratory.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for early diagnosis of diseases to reduce healthcare costs
    • 5.1.1.2. Growing development of disposable and low-cost LOC devices with sensors and other accessories
    • 5.1.1.3. Rising adoption of POC and LOC devices by governments to alleviate the rising healthcare expenditure
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standard reimbursement for POC devices with a cartridge that performs multiple tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in technology to increase research activities for the identification of novel biomarkers
    • 5.1.3.2. Emerging development of predictive-modeling techniques to analyze the LOC assays data for therapy monitoring
  • 5.1.4. Challenges
    • 5.1.4.1. Reduced accessibility and awareness among the population
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device Type: Expanding usage of point-of-care devices in diverse settings owing to their user-friendliness
  • 5.2.2. Application: Provision of comprehensive, advanced healthcare solutions in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Heart Failure POC & LOC Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Lab-on-a-Chip (LOC) Devices
• 6.3. Point-of-Care (POC) Devices

7. Heart Failure POC & LOC Devices Market, by Test Type

• 7.1. Introduction
• 7.2. Genomic Testing
• 7.3. Metabolomic Testing
• 7.4. Proteomic Testing

8. Heart Failure POC & LOC Devices Market, by Technology

• 8.1. Introduction
• 8.2. Electrochemical Sensing
• 8.3. Microfluidics
• 8.4. Optical Sensing

9. Heart Failure POC & LOC Devices Market, by Application

• 9.1. Introduction
• 9.2. Assisted Living Healthcare Facilities
• 9.3. Clinics
• 9.4. Home
• 9.5. Hospitals
• 9.6. Laboratory

10. Americas Heart Failure POC & LOC Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Heart Failure POC & LOC Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Heart Failure POC & LOC Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Roche Diagnostics India Launches NT-proBNP Test for Early Detection of Heart Failure in Diabetes Patients
  • 13.3.2. FDA Clears Eko Health's AI-Powered Stethoscope for Rapid Low Ejection Fraction Detection, Enhancing Early Heart Failure Diagnosis
  • 13.3.3. Roche to Acquire LumiraDx's Point-of-Care Technology in a USD 350 Million Deal, Aiming to Expand Decentralized Testing Portfolio
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACON Laboratories Inc.
• 3. AstraZeneca PLC
• 4. Becton, Dickinson and Company
• 5. bioMerieux SA
• 6. BioTelemetry, Inc. by Royal Philips
• 7. Boditech Med Inc.
• 8. Danaher Corporation
• 9. Eko Health, Inc.
• 10. F. Hoffmann-La Roche Ltd.
• 11. Jant Pharmacal Corporation
• 12. Johari Digital India Limited
• 13. Lepu Medical Technology(Beijing)Co.,Ltd.
• 14. Lupin Limited
• 15. Masimo Corporation
• 16. Medtronic PLC
• 17. Novartis AG
• 18. Quidel Corporation
• 19. Sanner GmbH
• 20. Siemens Healthineers AG
• 21. Trinity Biotech PLC
• 22. uFluidix Inc.

LIST OF FIGURES

• FIGURE 1. HEART FAILURE POC & LOC DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEART FAILURE POC & LOC DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEART FAILURE POC & LOC DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LAB-ON-A-CHIP (LOC) DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY POINT-OF-CARE (POC) DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GENOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY METABOLOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY PROTEOMIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ELECTROCHEMICAL SENSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY OPTICAL SENSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. POLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. QATAR HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2023